Lactobacillus casei: Influence on the innate immune response and haemostatic alterations in a liver-injury model

Canadian Journal of Microbiology

Volumn 55, Issue 6, 2009, Pages 648-656

  Haro, Cecilia ^a   Zelaya, Hortensia ^a   Lazarte, Sandra ^a   Alvarez, Susana ^a,b   Agüero, Graciela ^a  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

Author keywords

Acute liver injury; Blood coagulation; Lactobacillus casei

Indexed keywords

ACUTE LIVER INJURY; BLOOD COAGULATION; D-GALACTOSAMINE; DEAD CELLS; HEPATIC DAMAGE; HEPATOTOXINS; IMMUNE RESPONSE; INFLAMMATORY RESPONSE; INJURY MODELS; INNATE IMMUNE RESPONSE; INTRAPERITONEAL INJECTIONS; LACTOBACILLUS CASEI; LIVER INJURIES; LIVER TISSUE; MYELOPEROXIDASE; PLASMA FIBRINOGEN LEVELS; PREVENTIVE TREATMENTS; PROTHROMBIN TIME; WHITE BLOOD CELLS;

BLOOD; CELL MEMBRANES; COAGULATION; IMMUNOLOGY;

LIVER;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FIBRINOGEN; GALACTOSAMINE; MYELOPEROXIDASE; PROBIOTIC AGENT;

BACTERIUM; DISEASE RESISTANCE; ENZYME ACTIVITY; IMMUNE RESPONSE; INJURY; INNATE BEHAVIOR; MICROBIAL ACTIVITY; RODENT; SERUM; TOXIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CLOTTING; BLOOD SAMPLING; CELL COUNT; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; IMMUNOMODULATION; INNATE IMMUNITY; LACTOBACILLUS CASEI; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LIVER; LIVER INJURY; LIVER PROTECTION; MOUSE; NEUTROPHIL; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROTHROMBIN TIME; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; BLOOD CELL COUNT; GALACTOSAMINE; IMMUNITY, INNATE; LACTOBACILLUS CASEI; LIVER; LIVER DISEASES; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; PROBIOTICS;

LACTOBACILLUS CASEI; MUS;

EID: 67749108147     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W09-022     Document Type: Article

References (49)

1. Abbas, A., and Lichtman, A. 2004. Citoquinas. In Inmunología celular y molecular. Quinta ed. Edited by Elsevier España S.A. pp. 243-274.
2. Adawi, D., Ahrné, S., and Molin, G. 2001. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int. J. Food Microbiol. 70(3): 213-220. doi:10.1016/S0168-1605(01)00550-5.
3. Agüero, G., Villena, J., Racedo, S., Haro, C., and Alvarez, S. 2006. Beneficial immunomodulatory activity of Lactobacillus casei in malnourished mice pneumonia: effect on inflammation and coagulation. Nutrition, 22(7-8): 810-819. doi:10.1016/j.nut.2006.03.013. PMID:16815495.
4. Alvarez, S., Gobbato, N., Bru, E., Ruiz Holgado, A., and Perdigón, G. 1998. Specific immunity induction at mucosal level by viable Lactobacillus casei. Perspective for oral vaccine development. Food Agric. Immunol. 10(1): 79-87. doi:10.1080/09540109809354971.
5. Alvarez, S., Herrero, C., Bru, E., and Perdigón, G. 2001. Effect of Lactobacillus casei and yogurt administration on prevention of Pseudomonas aeruginosa infection in young mice. J. Food Prot. 64(11): 1768-1774. PMID:11726157.
6. Aoi, W., Naito, Y., Nakamura, T., Akagiri, S., Masuyama, A., Takano, T., et al. 2007. Inhibitory effect of fermented milk on delayed-onset muscle damage after exercise. J. Nutr. Biochem. 18(2): 140-145. doi:10.1016/j.jnutbio.2006.05. 002. PMID:16781862.
7. Bautista, A.P., Schuler, A., Spolarics, Z., and Spitzer, J.J. 1991. Tumor necrosis factor-α stimulates superoxide anion generation by perfused rat liver and Kupffer cells. Am. J. Physiol. 261(6 Pt 1): G891-G895. PMID:1662913.
8. Chandra, R.K. 2004. Micronutrients, probiotics, and the liver. J. Gastroenterol. Hepatol. 19(s7): S398-S400. doi:10.1111/j.1440-1746.2004.03711.x.
9. Chosay, J.G., Essani, N.A., Dunn, C.J., and Jaeschke, H. 1997. Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am. J. Physiol. 272(5 Pt. 1): G1195-G1200. PMID:9176230.
10. Cross, M.L. 2002. Immunoregulation by probiotic lactobacilli: pro Th1 signals and their relevance to human health. Clin. Appl. Immunol. Rev. 3(3): 115-125. doi:10.1016/S1529-1049(02)00057-0.
11. Dabos, K.J., Newsome, P.N., Parkinson, J.A., Davidson, J.S., Sadler, I.H., Plevris, J.N., and Hayes, P.C. 2005. A biochemical prognostic model of outcome in paracetamol-induced acute liver injury. Transplantation, 80(12): 1712-1717. doi:10.1097/01.tp.0000187879.51616.e0. PMID:16378066.
12. Dacie, J.V., and Lewis, S.M. 1995. Basic haematological techniques. In Practical haematology. 8th ed. Edited by J.V. Dacie and S.M. Lewis. Churchill Livingstone, Philadelphia, Penn.. pp. 49-82.
13. Ding, Y., Zhao, L., Huang, Z.H., Mei, H., and Peng, H.M. 2008. Role of early growth response factor-1 signal pathway in acute intrahepatic cholestatic hepatic injury in rats. Zhonghua Gan Zang Bing Za Zhi, 16(3): 215-219. [In Chinese.] PMID:18364083.
14. Drotman, R.B., and Lawhorn, G.T. 1978. Serum enzymes as indicators of chemically induced liver damage. Drug Chem. Toxicol. 1(2): 163-171. doi:10.3109/01480547809034433. PMID:755666.
15. Franková, D., and Zidek, Z. 1998. IFN-gamma-induced TNF-α is a prerequisite for in vitro production of nitric oxide generated in murine peritoneal macrophages by IFN-g. Eur. J. Immunol. 28(3): 838-843. doi:10.1002/(SICI)1521-4141(199803)28:03〈838::AID-IMMU838〉3.0.CO;2-T. PMID:9541578.
16. Galdeano, C.M., de Moreno de LeBlanc, A., Vinderola, G., Bonet, M.E., and Perdigón, G. 2007. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vaccine Immunol. 14(5): 485-492. doi:10.1128/CVI.00406-06. PMID:17360855.
17. Ganey, P.E., Luyendyk, J.P., Newport, S.W., Eagle, T.M., Maddox, J.F., Mackman, N., and Roth, R.A. 2007. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology, 46(4): 1177-1186. doi:10.1002/hep.21779. (Pubitemid 350144782)
18. Grupo CAHT. 2003. Coagulación: pruebas globales y determinación de factores. In Fundamentos para el manejo práctico en el laboratorio de hemostasia. Primera ed. Talleres Gráficos de la Federación Bioquímica de la Provincia de Buenos Aires. pp. 165-232.
19. Gujral, J.S., Farhood, A., Bajt, M.L., and Jaeschke, H. 2003. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology, 38(2): 355-363. doi:10.1053/jhep.2003.50341. PMID:12883479. (Pubitemid 36919856)
20. Holst, O., Ulmer, A.J., Brade, H., Flad, H.D., and Rietschel, E.T. 1996. Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol. Med. Microbiol. 16(2): 83-104. doi:10.1111/j.1574-695X.1996.tb00126.x. PMID:8988390.
21. Iwatsuki, S., and Starzl, T.E. 1988. Personal experience with 411 hepatic resections. Ann. Surg. 208(4): 421-434. doi:10.1097/00000658-198810000-00004. PMID:3178330.
22. Jensen, S.A. 2001. Liver gene regulation in rats following both 70% or 90% hepatectomy and endotoxin treatment. J. Gastroenterol. Hepatol. 16(5): 525-530. doi:10.1046/j.1440-1746.2001.02475.x. PMID:11350548.
23. Kano, H., Mogami, O., and Uchida, M. 2002. Oral administration of milk fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 to DBA/1 mice inhibits secretion of proinflammatory cytokines. Cytotechnology, 40(1-3): 67-73. doi:10.1023/A:1023966121989. PMID:19003106.
24. Kaplow, L.S. 1968. Simplified myeloperoxidase stain using benzidine dihydrochloride. Blood, 26: 215-220. PMID:14332483.
25. Kasravi, F.B., Adawi, D., Molin, G., Bengmark, S., and Jeppsson, B. 1997. Effect of oral supplementation of lactobacilli on bacterial translocation in acute liver injury induced by D-galactosamine. J. Hepatol. 26(2): 417-424. doi:10.1016/S0168-8278(97)80060-8. PMID:9059965. (Pubitemid 27077443)
26. Keppler, D., Lesch, R., Reutter, W., and Decker, K. 1968. Experimental hepatitis induced by D-galactosamine. Exp. Mol. Pathol. 9(2): 279-290. doi:10.1016/0014-4800(68)90042-7. PMID:4952077.
27. Kerr, R. 2003. New insights into haemostasis in liver failure. Blood Coagul. Fibrinolysis, 14(Suppl 1): S43-S45. doi:10.1097/00001721-200306001- 00011. PMID:14567536.
28. Kerr, R., Newsome, P., Germain, L., Thomson, E., Dawson, P., Stirling, D., and Ludlam, C.A. 2003. Effects of acute liver injury on blood coagulation. J. Thromb. Haemost. 1(4): 754-759. doi:10.1046/j.1538-7836.2003.00194.x. PMID:12871412.
29. Lacour, S., Gautier, J.C., Pallardy, M., and Roberts, R. 2005. Cytokines as potential biomarkers of liver toxicity. Cancer Biomark. 1(1): 29-39. PMID:17192030.
30. Lacroix-Desmazes, S., Navarrete, A.M., André, S., Bayry, J., Kaveri, S.V., and Dasgupta, S. 2008. Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A. Blood, 112(2): 240-249. doi:10.1182/blood-2008-02-124941. PMID:18469198.
31. Lavnikova, N., Drapier, J.C., and Laskin, D.L. 1993. A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity. J. Leukoc. Biol. 54(4):322-328. PMID:8409754.
32. Llopis, M., Antolin, M., Carol, M., Borruel, N., Casellas, F., Martinez, C., et al. 2009. Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's disease mucosa. Inflamm. Bowel Dis. 15(2): 275-283. doi:10.1002/ibd.20736. PMID:18839424.
33. Malhi, H., Gores, G.J., and Lemasters, J.J. 2006. Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology, 43(Suppl 1): S31-S44. doi:10.1002/hep.21062. PMID:16447272.
34. Noe, D.A., Murphy, P.A., Bell, W.R., and Siegel, J.N. 1989. Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am. J. Physiol. 257(1 Pt. 2): R49-R56. PMID:2473659.
35. Nurmi, J.T., Puolakkainen, P.A., and Rautonen, N.E. 2005. Bifidobacterium Lactis sp. 420 up-regulates cyclooxygenase (Cox)-1 and down-regulates Cox-2 gene expression in a Caco-2 cell culture model. Nutr. Cancer, 51(1): 83-92. doi:10.1207/s15327914nc5101-12. PMID:15749634.
36. Opal, S.M., and Esmon, C.T. 2003. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit. Care, 7(1): 23-38. doi:10.1186/cc1854. PMID:12617738.
37. Osman, N., Adawi, D., Ahrné, S., Jeppsson, B., and Molin, G. 2007. Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium, and blueberry. Dig. Liver Dis. 39(9): 849-856. doi:10.1016/j.dld.2007.06.001.
38. Pearson, J.M., Schultze, A.E., Jean, P.A., and Roth, R.A. 1995. Platelet participation in liver injury from gram-negative bacterial lipopolysaccharide in the rat. Shock, 4(3): 178-186. doi:10.1097/00024382-199509000-00005. PMID:8574752.
39. Peran, L., Camuesco, D., Comalada, M., Nieto, A., Concha, A., Diaz-Ropero, M.P., et al. 2005. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J. Gastroenterol. 11(33): 5185-5192. PMID:16127750.
40. Peran, L., Camuesco, D., Comalada, M., Bailon, E., Henriksson, A., Xaus, J., et al. 2007. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei, and Lactobacillus acidophilus, in the TNBS model of rat colitis. J. Appl. Microbiol. 103(4): 836-844. doi:10.1111/j.1365-2672.2007.03302.x. PMID:17897185.
41. Perdigón, G., Alvarez, S., Medina, M., Vintiñi, E., and Roux, E. 1999. Influence of the oral administration of lactic acid bacteria on iga producing cells associated to bronchus. Int. J. Immunopathol. Pharmacol. 12(2): 97-102. PMID:12783652.
42. Perdigón, G., Maldonado Galdeano, C., Valdez, J., and Medici, M. 2002. Interaction of lactic acid bacteria with the gut immune system. Eur. J. Clin. Nutr. 56(Suppl. 4): S21-S26. doi:10.1038/sj.ejcn.1601658. PMID:11840176.
43. Racedo, S., Villena, J., Medina, M., Agüero, G., Rodríguez, V., and Alvarez, S. 2006. Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect. 8(9-10): 2359-2366. doi:10.1016/j.micinf.2006.04.022. PMID:16904925.
44. Roselli, M., Finamore, A., Britti, M.S., and Mengheri, E. 2006. Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco-2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br. J. Nutr. 95(6): 1177-1184. doi:10.1079/BJN20051681. PMID:16768842. (Pubitemid 43985998)
45. Tok, D., Ilkgul, O., Bengmark, S., Aydede, H., Erhan, Y., Taneli, F., et al. 2007. Pretreatment with pro- and synbiotics reduces peritonitis-induced acute lung injury in rats. J. Trauma, 62(4): 880-885. doi:10.1097/01.ta. 0000236019.00650.00. PMID:17426542. (Pubitemid 46624204)
46. Villena, J., Racedo, S., Agüero, G., Bru, E., Medina, M., and Alvarez, S. 2005. Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice. J. Nutr. 135(6): 1462-1469. PMID:15930453.
47. WHO/FAO. 2006. World Health Organization, Food and Agriculture Organization of the United Nations. Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO Food and Nutrition Paper 85. Available from ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf.
48. Williams, R., and Gimson, A.E.S. 1991. Intensive liver care and management of acute hepatic failure. Dig. Dis. Sci. 36(6): 820-826. doi:10.1007/BF01311243. PMID:1903343.
49. Wu, J., Danielsson, A., and Zern, M.A. 1999. Toxicity of hepatotoxins: new insights into mechanisms and therapy. Expert Opin. Investig. Drugs, 8(5): 585-607. doi:10.1517/13543784.8.5.585. PMID:15992118.